Paris - New options for treatment and prevention of severe drug eruptions are likely on the horizon thanks to recent advances in understanding the mechanisms of these reactions, Jean-Claude Roujeau, M.D., said at the World Congress of Dermatology.
Patients With Hidradenitis Suppurativa Have Increased Odds of Respiratory Disease, According to Study Findings
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and Workers
ReV Up Your Vitiligo Treatment Strategies
US Central and European Commands Should Revisit Disallowance of Systemic Treatments for Deployed Individuals With Psoriasis, Eczema, Paper Argues
Ruxolitinib, Educational Initiatives for Managed Care Professionals Play Crucial Role in Optimizing Care in Atopic Dermatitis